Intermittent claudication a controlled study in parallel time of the short-term and long-term effects of cinnarizine

Intermittent claudication : a controlled study in parallel time of the short-term and long-term effects of cinnarizine

In a group of 45 patients with mild to moderately severe claudication studied over the same 4-month period, cinnarizine administration (75 mg 3-times daily) was associated with a greater than 20% improvement in walking distance in 65% of the patients, who derived significantly more benefit than the...

Description complète

Détails bibliographiques
Publié dans:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC). - 1995. - 2(1980), 6 vom: 08., Seite 401-7
Auteur principal: Barber, J H (Auteur)
Autres auteurs: Reuter, C A, Jageneau, A H, Loots, W
Format: Article
Langue:English
Publié: 1980
Accès à la collection:Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)
Sujets:Clinical Trial Journal Article Randomized Controlled Trial Piperazines Cinnarizine 3DI2E1X18L